John Ware to 5-alpha Reductase Inhibitors
This is a "connection" page, showing publications John Ware has written about 5-alpha Reductase Inhibitors.
Connection Strength
0.104
-
Moinpour CM, Darke AK, Donaldson GW, Cespedes D, Johnson CR, Ganz PA, Patrick DL, Ware JE, Shumaker SA, Meyskens FL, Thompson IM. Health-related quality-of-life findings for the prostate cancer prevention trial. J Natl Cancer Inst. 2012 Sep 19; 104(18):1373-85.
Score: 0.104